IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Strides Arcolab to Up Production

7:30 AM MDT | May 11, 2009

Pharmaceutical firm Strides Arcolab (Bangalore) says it has begun supplying Oseltamivir capsules, the generic equivalent of Roche’s Tamiflu, to various countries for swine flu treatment. Strides Arcolab, one of few approved Oseltamivir manufacturers in India, plans to start producing more than 2 million doses/month in June, as there are only limited stocks currently available, the company says. Strides Arcolab manufactures Oseltamivir at its U.S. FDA-approved and WHO-prequalified facility at Bangalore. “We are particularly well equipped to handle...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa